久久视频在线视频精品-日韩亚洲变态另类中文-free性欧美69巨大-mm131巨爆乳美女少妇动态图

MicroPort Endovascular (Shanghai) Co ("MicroPort? Endovascular") recently gained the registration certificate for its in-house developed Hercules? Balloon Inflation Catheter from Brazil's National Health Surveillance Agency.

Hercules? Balloon Inflation Catheter is indicated for enhancing the vessel wall apositioning of self-expandable graft-stent. It can effectively enhance graft-stent expansion, avoid incomplete vessel wall apositioning, eliminate aneurysm endoleak risk, and ensure precise deployment.

Hercules? Balloon Inflation Catheter is designed to work with MicroPort? Endovascular's Hercules? Thoracic Stent-Graft System and Hercules Bifurcated Stent-Graft System. With Hercules? Balloon Inflation Catheter's market launch approval in Brazil, the entire serial of MicroPort? Endovascular's Hercules? products have been launched in the local market, which will better serve the need of surgeons and further expand the company's overseas market.

MicroPort Scientific Corporation (the "Group") is a leading medical device company with business focusing on innovating, manufacturing, and marketing high-quality and high-end medical devices globally. With a diverse portfolio of products now being used at an average rate of one for every 18 seconds in thousands of major hospitals around the world, the Group maintains world-wide operations in a broad range of business segments including Cardiovascular, Orthopedic, Electrophysiological, Endovascular, Neurovascular, Surgical, Diabetes Care and Endocrinal Management, and others. MicroPort? is dedicated to becoming a patient oriented global enterprise improve and reshape patient lives through application of innovative science and technology.